STING1 and neoplasm: Interestingly, mice treated with the combination therapy gained protection against tumor rechallenge, suggesting that the combination therapy led to long-term tumor-specific memory, which was not observed in any single therapy.220 It is noteworthy that the formation of immune memory by STING agonists does not necessarily depend on ICBs.